Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Grant or award Director acquired 7,643 shares (grant or award)
  2. 4 Grant or award Director acquired 5,925 shares (grant or award)
  3. 4 Open-market buy President and CEO bought 4,200 shares at an average $2.40 ($10,068)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy President and CEO bought 2,500 shares at an average $2.07 ($5,176)
  6. 4 Open-market buy President and CEO bought 2,500 shares at $1.98 ($4,950)
  7. 4 Open-market sale Chief Medical Officer sold 8,435 shares at $2.01 ($16,954)
  8. 4 Grant or award Director acquired 2,734 shares (grant or award)
  9. 4 Grant or award Director acquired 4,843 shares (grant or award)
  10. 4 Grant or award Director acquired 2,968 shares (grant or award)
  11. 4 Grant or award Director acquired 2,734 shares (grant or award)
  12. 4 Grant or award Director acquired 3,750 shares (grant or award)
  13. 4 Grant or award Director acquired 3,125 shares (grant or award)
  14. 4 Grant or award Director acquired 2,968 shares (grant or award)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 7,895 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Medical Officer gave up 7,154 shares (to pay taxes)
  17. 4 Shares withheld for taxes President and CEO gave up 15,159 shares (to pay taxes)
  18. 4 Shares withheld for taxes Vice President of Operations gave up 6,185 shares (to pay taxes)
  19. 4 Grant or award Director acquired 4,531 shares (grant or award)
  20. 4 Grant or award Director acquired 2,734 shares (grant or award)

Page 10 of 23 · 442 filings